Executive chair Peter J. Pitts signs new agreement effective July 24, 2026
Brainstorm Cell Therapeutics has announced the employment of Peter J. Pitts as Executive Chairman and Chief Strategic Regulatory Officer. The agreement outlines a compensation structure with no base salary or formal bonus, effective upon his joining the board, subject to shareholder approval.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day